X-136648286-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_000074.3(CD40LG):c.38C>T(p.Ala13Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,198,572 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 60 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000074.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD40LG | NM_000074.3 | c.38C>T | p.Ala13Val | missense_variant | 1/5 | ENST00000370629.7 | NP_000065.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD40LG | ENST00000370629.7 | c.38C>T | p.Ala13Val | missense_variant | 1/5 | 1 | NM_000074.3 | ENSP00000359663 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000108 AC: 12AN: 111372Hom.: 0 Cov.: 22 AF XY: 0.0000894 AC XY: 3AN XY: 33564
GnomAD3 exomes AF: 0.0000819 AC: 15AN: 183233Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67739
GnomAD4 exome AF: 0.000147 AC: 160AN: 1087200Hom.: 0 Cov.: 28 AF XY: 0.000161 AC XY: 57AN XY: 353256
GnomAD4 genome AF: 0.000108 AC: 12AN: 111372Hom.: 0 Cov.: 22 AF XY: 0.0000894 AC XY: 3AN XY: 33564
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 23, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 18, 2016 | - - |
Hyper-IgM syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at